1. Bacteria resist nitrofurantoin by reducing uptake or altering target enzymes. Control involves prudent use and monitoring resistance patterns.

2. To combat nitrofurantoin resistance, bacteria might modify its ribosomal targets or efflux the drug. Providers should employ antibiotic stewardship.

3. Bacterial resistance to nitrofurantoin can occur via mutated enzymes and efflux pumps. Healthcare strategies include targeted therapy based on culture results.

4. Resistance mechanisms include enzymatic inactivation and modified drug targets. To mitigate, healthcare workers should use surveillance data to guide prescribing.

5. Bacteria develop nitrofurantoin resistance by impeding drug entry and inactivating it enzymatically. Addressing this involves strict antibiotic stewardship policies.